Published in Rev Esp Cardiol on January 01, 1991
Is tricuspid valve repair necessary? J Thorac Cardiovasc Surg (1980) 1.17
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations. J Med Virol (2001) 1.14
[Percutaneous mitral valvuloplasty. Immediate results with the 30 mm diameter dilatation balloon]. Rev Esp Cardiol (1992) 1.09
Intraoperative assessment of mitral valve function. Ann Thorac Surg (1978) 0.98
Right ventriculography as a valid method for the diagnosis of tricuspid insufficiency. Cathet Cardiovasc Diagn (1981) 0.91
Clinical and hemodynamic performance of a totally flexible prosthetic ring for atrioventricular valve reconstruction. Ann Thorac Surg (1976) 0.90
Conservative operation for mitral insufficiency: critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg (1980) 0.88
Analysis of the amount of tricuspid valve anular dilatation required to produce functional tricuspid regurgitation. Am J Cardiol (1983) 0.87
Incidence of primary tissue valve failure with the Ionescu-Shiley pericardial valve. Preliminary results. J Thorac Cardiovasc Surg (1985) 0.86
Coronary arteriography and atrial thrombosis in mitral valve disease. Am J Cardiol (1981) 0.85
In vivo experimental assessment of polytetrafluoroethylene trileaflet heart valve prosthesis. J Thorac Cardiovasc Surg (1990) 0.84
The behavior of pericardial versus porcine valve xenografts in the growing sheep model. J Thorac Cardiovasc Surg (1987) 0.81
Hemodynamic factors that affect calculated orifice areas in the mitral hancock xenograft valve. Circulation (1980) 0.81
Comparative study of primary tissue valve failure between Ionescu-Shiley pericardial and Hancock porcine valves in the aortic position. Am J Cardiol (1986) 0.81
Six- to ten-year follow-up of patients with the Hancock cardiac bioprosthesis. Incidence of primary tissue valve failure. J Thorac Cardiovasc Surg (1986) 0.80
Primary tissue valve degeneration in glutaraldehyde-preserved porcine bioprostheses: Hancock I versus Carpentier-Edwards at 4- to 7-years' follow-up. Ann Thorac Surg (1986) 0.80
Experimental atrioventricular bioprosthetic valve insertion: a simple and successful technique. Thorac Cardiovasc Surg (1983) 0.80
Degeneration in porcine bioprosthetic cardiac valves: incidence of primary tissue failures among 938 bioprostheses at risk. Am J Cardiol (1984) 0.79
Composite pericardial monocusp patch for the reconstruction of right ventricular outflow tract. Clinical application in 7 patients. Thorac Cardiovasc Surg (1983) 0.78
[Mitral valve substitution by Hancock bioprosthesis]. Rev Esp Cardiol (1979) 0.78
Four- to seven-year follow-up of patients undergoing Carpentier-Edwards porcine heart valve replacement. Thorac Cardiovasc Surg (1985) 0.77
Isolated mitral valve replacement with the Hancock porcine bioprosthesis in rheumatic heart disease: analysis of 213 operative survivors followed up 4.5 to 8.5 years. Am J Cardiol (1984) 0.77
Degenerative pathologic findings after long-term implantation of bovine pericardial bioprosthetic heart valves. J Thorac Cardiovasc Surg (1988) 0.77
[Surgery for active valvular endocarditis]. Rev Esp Cardiol (2001) 0.75
Heparin-coated circuit in coronary surgery. A clinical study. Eur J Cardiothorac Surg (1996) 0.75
[Coronary revascularization surgery with arterial grafts]. Rev Esp Cardiol (1998) 0.75
Early clinical results with the Xenomedica porcine bioprosthesis. Thorac Cardiovasc Surg (1985) 0.75
[Guide for the evaluation of new heart valve prostheses]. Rev Esp Cardiol (1988) 0.75
[Isolated aortic valve replacement with a bioprosthesis. Results after an 8-years follow-up]. Rev Esp Cardiol (1984) 0.75
[A new method of right ventriculography for diagnosing tricuspid valve insufficiency]. Rev Esp Cardiol (1981) 0.75
[Tissue degeneration of bioprostheses]. Ann Chir (1987) 0.75
[Valve grafts: problems and results]. Ann Cardiol Angeiol (Paris) (1977) 0.75
The Ionescu-Shiley valve: a solution for the small aortic root. J Thorac Cardiovasc Surg (1984) 0.75
[Myocardial revascularization with the gastroepiploic artery. The initial experience]. Rev Esp Cardiol (1991) 0.75
[Analysis of the results of 212 flexible annuloplasties in mitral position]. Rev Esp Cardiol (1980) 0.75
[Substitutes for a heterologous pericardium: a call to attention]. Rev Esp Cardiol (1987) 0.75
In situ right gastroepiploic artery. A conduit for coronary revascularization. Eur J Cardiothorac Surg (1991) 0.75
[Turner's syndrome in the newborn infant. Case report]. Pathologica (1974) 0.75
Comparative study of calcification in the T6-treated and standard Hancock-I porcine xenografts: experimental study in weanling sheep. Thorac Cardiovasc Surg (1986) 0.75
Five- to eight-year follow-up of patients with the Hancock cardiac bioprosthesis. J Thorac Cardiovasc Surg (1983) 0.75
[Aspects of pathology of the reticuloendothelium in childhood]. Chir Ital (1967) 0.75
Pericardial substitutes: animal versus clinical results. J Thorac Cardiovasc Surg (1988) 0.75
Clinical experience with the Carpentier-Edwards porcine bioprosthesis: short-term results (from 2 to 4.5 years). Thorac Cardiovasc Surg (1983) 0.75
[Dilatation of coronary stenosis by percutaneous transluminal angioplasty]. Rev Esp Cardiol (1981) 0.75
[Percutaneous valvuloplasty in severe sclero-degenerative aortic stenosis in adults: preliminary results]. Rev Esp Cardiol (1987) 0.75
Calcified constrictive pericarditis. Ultrasonic debridement. Eur J Cardiothorac Surg (1991) 0.75
[Percutaneous cardiopulmonary bypass in angioplasty and valvuloplasty. The technical considerations]. Rev Esp Cardiol (1991) 0.75
[A primary epithelioid hemangioendothelioma localized in the pulmonary valve]. Rev Esp Cardiol (1991) 0.75
Late clinical results with the use of heterologous pericardium for closure of the pericardial cavity. J Thorac Cardiovasc Surg (1985) 0.75
[Behavior of sensitivity to tolbutamide in thymectomized rats]. Boll Soc Ital Biol Sper (1966) 0.75